1
Matsumoto Takahiro, Kori Masakuni, Miyazaki Junichi, Kiyota Yoshihiro: (Ja) アミド化合物, (En) Amide compound. Takeda Pharmaceutical Company, Matsumoto Takahiro, Kori Masakuni, Miyazaki Junichi, Kiyota Yoshihiro, KAWAMIYA Osamu, May 26, 2006: WO/2006/054652 (20 worldwide citation)

(EN) An FAAH inhibitor; and a preventive/therapeutic agent for cerebrovascular disorders and a preventive/therapeutic agent for sleep disorders which each contains the inhibitor. The FAAH inhibitor is a compound represented by the formula (I0): (wherein Z represents oxygen or sulfur; R1 represents o ...


2
Shirai Junya, Matsumoto Takahiro, Kamo Izumi: (Ja) ベンゾオキサゼピン誘導体およびその用途, (En) Benzoxazepine derivatives and use thereof. Takeda Pharmaceutical Company, Shirai Junya, Matsumoto Takahiro, Kamo Izumi, TAKASHIMA Hajime, September 12, 2008: WO/2008/108445 (19 worldwide citation)

(EN) Compounds represented by the general formula (I) wherein each symbol is as defined in the description [with the proviso that 9-chloro-7-(1,1-dimethylethyl)-2,3,4,5-tetrahydro-1,4-benz-oxazepine and N-[[(5S)-2-oxo-3-(2,3,4,5-tetrahydro-1,4- benz- oxazepin-7-yl)-5-oxazolidinyl]methyl]acetamide ar ...


3
Matsumoto Takahiro, Kamo Izumi, Nomura Izumi: Tricyclic heterocyclic compound and use thereof. Takeda Pharmaceutical Company, Matsumoto Takahiro, Kamo Izumi, Nomura Izumi, TAKASHIMA Hajime, January 17, 2008: WO/2008/007661 (14 worldwide citation)

Disclosed is a tricyclic heterocyclic compound having a serotonin 5-HT2C receptor activating effect and the like. Specifically disclosed is a serotonin 5-HT2C receptor activator containing a compound represented by the formula (I) below, a salt thereof or a prodrug thereof. (I) (In the formula, the ...


4
Shinkai Seiji, Mizu Masami, Sakurai Kazuo, Koumoto Kazuya, Numata Munenori, Matsumoto Takahiro: (Ja) 免疫刺激剤, (En) Immunostimulant. Japan Science and Technology Agency, Mitsui Sugar, Shinkai Seiji, Mizu Masami, Sakurai Kazuo, Koumoto Kazuya, Numata Munenori, Matsumoto Takahiro, TSUTSUI Satoru, November 25, 2004: WO/2004/100965 (9 worldwide citation)

(EN) An immunostimulant of a novel type which is a complex of an immunostimulant oligonucleotide with a carrier having a high safety and a high transfection effect. A complex comprising an immunostimulant oligonucleotide and a polysaccharide having a &bgr;-1,3-bond (preferably a &bgr;-1,3-glucan suc ...


5
Matsumoto Takahiro, Kori Masakuni, Kouno Mitsunori: (Ja) 脳・神経細胞保護剤および睡眠障害治療薬, (En) Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder. Takeda Pharmaceutical Company, Matsumoto Takahiro, Kori Masakuni, Kouno Mitsunori, KAWAMIYA Osamu, February 22, 2007: WO/2007/020888 (8 worldwide citation)

(EN) A compound represented by the formula (I) or a salt thereof; and an agent for protecting a brain/neuronal cell or a therapeutic agent for sleep disorder comprising the compound or salt: wherein Z represents an oxygen or sulfur; R1 represents an aryl or heterocyclic group which may be substitute ...


6
Matsumoto Takahiro, Nagamiya Hiroyuki, Maezaki Hironobu, Kusumoto Tomokazu, Yoshikawa Kyoko, Furukawa Hideki, Kamo Izumi: (Ja) 縮合ピリジン誘導体およびその用途, (En) Condensed pyridine derivative and use thereof. Takeda Pharmaceutical Company, Matsumoto Takahiro, Nagamiya Hiroyuki, Maezaki Hironobu, Kusumoto Tomokazu, Yoshikawa Kyoko, Furukawa Hideki, Kamo Izumi, TAKASHIMA Hajime, May 22, 2009: WO/2009/063992 (6 worldwide citation)

(EN) Provided are a condensed pyridine derivative having an action of activating a serotonin 5HT2c receptor, a preventive or therapeutic agent for a disease such as lower urinary tract symptom, obesity and/or organ prolapse containing the condensed pyridine derivative, a screening method for a subst ...


7
Matsumoto Takahiro, Nagamiya Hiroyuki, Shirai Junya, Kusumoto Tomokazu: (Ja) 縮合ピリジン誘導体およびその用途, (En) Fused pyridine derivative and use thereof. Takeda Pharmaceutical Company, Matsumoto Takahiro, Nagamiya Hiroyuki, Shirai Junya, Kusumoto Tomokazu, TAKASHIMA Hajime, May 22, 2009: WO/2009/063993 (5 worldwide citation)

(EN) Disclosed is a serotonin 5-HT2c receptor activator containing a compound represented by the formula (I) below or a salt thereof. (In the formula, the symbols are as defined in the description.)(JA)  本発明は、式:[式中、各記号は明細書中と同義を示す]で表される化合物またはその塩を含有してなるセロトニン5-HT2c受容体活性化剤に関する。


8
Matsumoto Takahiro, Kurasawa Osamu, Oda Tsuneo, Nagabukuro Hiroshi, Mochizuki Manabu: (Ja) ピロロピリジン誘導体およびその用途, (En) Pyrrolopyridine derivative and use thereof. Takeda Pharmaceutical Company, Matsumoto Takahiro, Kurasawa Osamu, Oda Tsuneo, Nagabukuro Hiroshi, Mochizuki Manabu, TAKAHASHI Shuichi, January 22, 2004: WO/2004/007495 (3 worldwide citation)

(EN) A novel pyrrolopyridine derivative which is a compound represented by the formula (1) (wherein ring A represents an optionally substituted pyridine ring; X represents an electron-attracting group; Y represents an optionally substituted, divalent, C1-6 chain hydrocarbon group; R1 represents an o ...


9
Matsumoto Takahiro, Yamada Toshiaki, Tsuruya Hirotaka, Goto Takuya, Fujiwara Masahiro: (Ja) 絶縁化超微粉末および高誘電率樹脂複合材料, (En) Insulated ultrafine powder and high dielectric constant resin composite material. Mitsubishi Gas Chemical Company, Matsumoto Takahiro, Yamada Toshiaki, Tsuruya Hirotaka, Goto Takuya, Fujiwara Masahiro, OHTANI Tamotsu, February 9, 2006: WO/2006/013947 (2 worldwide citation)

(EN) An insulated ultrafine powder comprising a conductive ultrafine powder furnished with an insulating coating film, characterized in that the conductive ultrafine powder is constituted of a carbon material being in the form of a sphere of 1 to 500 nm particle diameter, a fiber of 1 to 500 nm cros ...


10
Matsumoto Takahiro, Kamo Izumi: Bicyclic heterocyclic compound and use thereof. Takeda Pharmaceutical Company, Matsumoto Takahiro, Kamo Izumi, TAKASHIMA Hajime, January 17, 2008: WO/2008/007664 (1 worldwide citation)

Disclosed is a bicyclic heterocyclic compound having a serotonin 5-HT2C receptor-activating activity and the like. Specifically, disclosed is a compound represented by the formula (I) or a salt thereof. (I) wherein each symbols are as defined in the description.